Speaking of which, manufacturing vitamin C was much simpler than producing penicillin medications.
After nearly a year of exploration and research, the Pharmaceutical Group had already realized the plan for the large-scale production of vitamin medications and introduced the world's first vitamin C-rich medicine—Vitamin C chewable tablets.
This was a "medication" that could either be taken orally or dropped into water to give the liquid a fruity flavor.
To break this medicine into the sales market, the Pharmaceutical Group aggressively publicized the dangers of vitamin C deficiency to the human body, using the scurvy that frequently plagued sailors on ocean voyages centuries ago as their primary example.
The results were obvious: historically documented events were definitely more convincing to people than some experiments.
People began to understand vitamin C, the dangers of lacking it, and actively supplemented their diets with it.
Because of this, these tablets, capable of providing massive amounts of vitamin C, were hyped up to astronomical prices by major sales channels.
Currently, the retail price of a regular box of vitamin C medicine was second only to penicillin, boasting a profit margin as high as 1,000%.
This was the benefit of an exclusive monopoly. Before other pharmaceutical enterprises developed their own vitamin C drugs, the Pharmaceutical Group's vitamin C medicine could command any exorbitant price and people would still accept it.
Arthur understood that other pharmaceutical companies and organic chemists would eventually discover vitamin C, and he had no intention of monopolizing its production and sales forever.
He intended to seize as much profit as possible while the current market vacuum lasted.
Of course, all of this was the Pharmaceutical Group's plan and had nothing to do with Arthur.
On the surface, the Pharmaceutical Group had no connection to Arthur whatsoever, aside from 1% of the tax